Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 22, Art. 47 (pp. 666-676)    |    2021       

»

Possibilities of circular scleral buckling in surgical treatment of recurrent retinal detachments.

Shishkin M. M., Fayzrakhmanov R.R., Kocheva E.A.

National Medical and Surgical Center named after N.I. Pirogov

Brief summary

Aim: To evaluate the effectiveness of circular scleral buckling in treatment of recurrent rhegmatogenous retinal detachments complicated by proliferative vitreoretinopathy C type 4 after a primary vitrectomy. Material and methods: Results of surgical treatment of 40 patients (40 eyes) with a recurrent retinal detachment after a primary vitrectomy were analyzed. All patients were divided into two groups according to the technique of surgery: In the Group I patients were reoperated through 25 G vitreoretinal surgery in combination with retinotomy, a silicone oil exchange or endotamponade of silicone oil; in the Group II circular scleral buckling was performed, in some cases with a combination with a repeated vitreoretinal surgery. Results: Preliminary results of the study indicate a high efficiency of circular scleral buckling in treatment of arecurrent rhegmatogenous retinal detachment after a primary vitreoretinal surgery. Conclusions: The use of circular scleral buckling in treatment of arecurrent rhegmatogenous retinal detachment after a primary vitrectomy demonstrates a safer and more sparing attitude to aretina, and also allows to achieve favorable functional and anatomical results.


Key words

circular scleral buckling; rhegmatogenous retinal detachment; vitreoretinal surgery; retina; retinotomy;

Reference list

1. Nagpal M, Chaudhary P, Wachasundar S, Eltayib A, Raihan A. Management of recurrent rhegmatogenous retinal detachment. Indian J Ophthalmol. 2018;66(12):1763-1771. doi: 10.4103/ijo.IJO_1212_18.


2. Charteris DG, Downie J, Aylward GW, Sethi C, Luthert P. Intraretinal and periretinal pathology in anterior proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol. 2007;245(1):93-100. doi: 10.1007/s00417-006-0323-5.


3. Di Lauro S, Kadhim MR, Charteris DG, Pastor JC. Classifications for Proliferative Vitreoretinopathy (PVR): An Analysis of Their Use in Publications over the Last 15 Years. J Ophthalmol. 2016;2016:7807596. doi: 10.1155/2016/7807596.


4. Pastor JC, de la Rúa ER, Martín F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res. 2002;21(1):127-44. doi: 10.1016/s1350-9462(01)00023-4.


5. Diddie KR, Azen SP, Freeman HM, Boone DC, Aaberg TM, Lewis H, Radtke ND, Ryan SJ. Anterior proliferative vitreoretinopathy in the silicone study. Silicone Study Report Number 10. Ophthalmology. 1996;103(7):1092-9. doi: 10.1016/s0161-6420(96)30562-9.


6. Aaberg TM. Management of anterior and posterior proliferative vitreoretinopathy. XLV. Edward Jackson memorial lecture. Am J Ophthalmol. 1988;106(5):519-32. doi: 10.1016/0002-9394(88)90580-6.


7. Federman JL, Schubert HD. Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology. 1988;95(7):870-6. doi: 10.1016/s0161-6420(88)33080-0.


8. de Silva DJ, Kwan A, Bunce C, Bainbridge J. Predicting visual outcome following retinectomy for retinal detachment. Br J Ophthalmol. 2008;92(7):954-8. doi: 10.1136/bjo.2007.131540.


9. Flaxel CJ, Mitchell SM, Aylward GW. Visual outcome after silicone oil removal and recurrent retinal detachment repair. Eye (Lond). 2000;14(6):834-8. doi: 10.1038/eye.2000.232.


10. Wang A, Snead MP. Scleral buckling-a brief historical overview and current indications. Graefes Arch Clin Exp Ophthalmol. 2020;258(3):467-478. doi: 10.1007/s00417-019-04562-1.


11. Hocaoglu M, Karacorlu M, Giray Ersoz M, Sayman Muslubas I, Arf S. Retinotomy and retinectomy for anterior inferior proliferative vitreoretinopathy: Can visual outcome be improved? Eur J Ophthalmol. 2021; 22(3): 67-74. doi: 10.1177/11206721211012848.


12. Quiram PA, Gonzales CR, Hu W, Gupta A, Yoshizumi MO, Kreiger AE, Schwartz SD. Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy. Ophthalmology. 2006 ;113(11):2041-7. doi: 10.1016/j.ophtha.2006.05.039.


13. Machemer R. Schneiden der Netzhaut: Eine Behandlungsmöglichkeit zur Wiederanlegung der Netzhaut [Cutting of the retina: a means of therapy for retinal reattachment (author's transl)]. Klin Monbl Augenheilkd. 1979;175(5):597-601. German. PMID: 547089.


14. Bai JX, Zhang XJ, Duan AL, Peng XY. Outcome of scleral buckling with or without gas tamponade for recurrent retinal detachment in post-vitrectomy eyes. BMC Ophthalmol. 2021;21(1):109. doi: 10.1186/s12886-021-01873-y.


15. Tatsumi T, Baba T, Iwase T, Nizawa T, Miura G, Yokouchi H, Yamamoto S. Outcomes of Vitrectomy Combined with Scleral Buckling for Eyes with Early Recurrence of Simple Rhegmatogenous Retinal Detachment Previously Treated by Pars Plana Vitrectomy. J Ophthalmol. 2020;2020:6637143. doi: 10.1155/2020/6637143.


16. Cox MS, Trese MT, Murphy PL. Silicone oil for advanced proliferative vitreoretinopathy. Ophthalmology. 1986;93(5):646-50. doi: 10.1016/s0161-6420(86)33686-8.


17. McCuen BW 2nd, Landers MB 3rd, Machemer R. The use of silicone oil following failed vitrectomy for retinal detachment with advanced proliferative vitreoretinopathy. Ophthalmology. 1985;92(8):1029-34. doi: 10.1016/s0161-6420(85)33904-0.


18. Gupta B, Mokete B, Laidlaw DA, Williamson TH. Severe folding of the inferior retina after relaxing retinectomy for proliferative vitreoretinopathy. Eye (Lond). 2008;22(12):1517-9. doi: 10.1038/eye.2008.220.